Andersen-Gill model for the endpoint OS
| . | RFS . | ||
|---|---|---|---|
| Prognostic markers . | HR . | 95%-CI . | P . | 
| Allogeneic HSCT | 0.50 | 0.21-1.17 | .11 | 
| Autologous HSCT | 0.57 | 0.23-1.40 | .22 | 
| Log10(WBC) | 1.34 | 0.64-2.80 | .44 | 
| Log10(platelets) | 0.95 | 0.40-2.26 | .91 | 
| % BM blasts (difference 10%) | 1.04 | 0.87-1.24 | .69 | 
| Age (difference of 10 y) | 1.08 | 0.82-1.42 | .59 | 
| Abnormal karyotype | 1.14 | 0.55-2.34 | .73 | 
| . | RFS . | ||
|---|---|---|---|
| Prognostic markers . | HR . | 95%-CI . | P . | 
| Allogeneic HSCT | 0.50 | 0.21-1.17 | .11 | 
| Autologous HSCT | 0.57 | 0.23-1.40 | .22 | 
| Log10(WBC) | 1.34 | 0.64-2.80 | .44 | 
| Log10(platelets) | 0.95 | 0.40-2.26 | .91 | 
| % BM blasts (difference 10%) | 1.04 | 0.87-1.24 | .69 | 
| Age (difference of 10 y) | 1.08 | 0.82-1.42 | .59 | 
| Abnormal karyotype | 1.14 | 0.55-2.34 | .73 | 
WBC, white blood cell count.